NOCD is a technology company.
NOCD has raised $84.0M across 5 funding rounds.
Key people at NOCD.
NOCD has raised $84.0M in total across 5 funding rounds.
Key people at NOCD.
NOCD has raised $84.0M in total across 5 funding rounds.
NOCD's investors include 7wire Ventures, Advent Life Sciences, Draper Associates, F-Prime Capital Partners, General Catalyst, Global Ventures, Latitud, Maverick Capital, Picus Capital, Questa Capital, Curtis Chambers.
NOCD is a Chicago-based digital health company providing specialized telehealth treatment for obsessive-compulsive disorder (OCD), primarily through Exposure and Response Prevention (ERP) therapy—the gold standard for OCD.[1][2][3][5] It connects users with licensed OCD-specialist therapists via live video sessions, supplemented by 24/7 in-app tools, self-help resources, and a peer community of nearly one million members, serving individuals across diverse backgrounds while accepting most insurance plans for about half of Americans.[1][3][5] NOCD addresses the severe shortage of OCD specialists by delivering virtual ERP twice as fast as traditional methods, with peer-reviewed studies showing effectiveness for around 90% of members and partnerships with major insurers driving growth.[3][5]
NOCD was founded around 2014-2015 by Stephen Smith (CEO), who has OCD himself, alongside a team many of whom share lived experience with the condition, driven by a mission to restore hope through better awareness and accessible treatment.[1][3][4] The idea emerged from personal challenges and the lack of effective OCD care, evolving into the world's largest OCD community and leading telehealth provider over the past decade, marked by pivotal scaling through insurance partnerships and clinician-led innovations.[3] Key leaders like Jamie Feusner (Chief Medical Officer), a scaling expert, emphasize the mission-driven team's accountability to members, enabling rapid growth while prioritizing treatment experience.[3]
NOCD rides the telehealth and digital mental health boom, capitalizing on post-pandemic demand for accessible behavioral care amid therapist shortages, especially for underserved OCD (one of the most severe yet misunderstood conditions).[1][4][5] Timing aligns with insurer adoption of virtual platforms and AI-enhanced tools in competitors like NeuroFlow or Youper, but NOCD's specialist focus differentiates it in a commoditizing market.[1] It influences the ecosystem by proving scalable ERP, building massive communities, and validating outcomes through research, pushing payers toward evidence-based digital therapies.[3][5]
NOCD is poised for expansion through deeper insurance integrations, app enhancements, and potential AI for personalization, amid rising mental health investment despite telehealth scrutiny.[1][3] Trends like integrated behavioral-physical health and wearables (e.g., competitors' approaches) will shape it, potentially evolving NOCD into a broader platform while maintaining OCD leadership.[1] Its community-driven model positions it to sustain influence, turning specialized telehealth into a hope-restoring force as in its founding mission.[3]
NOCD has raised $84.0M across 5 funding rounds. Most recently, it raised $34.0M Series B in January 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2023 | $34.0M Series B | 7wire Ventures, Advent Life Sciences, Draper Associates, F-Prime Capital Partners, General Catalyst, Global Ventures, Latitud, Maverick Capital, Picus Capital, Questa Capital, Curtis Chambers | |
| Sep 1, 2021 | $33.0M Series B | 7wire Ventures, Advent Life Sciences, Draper Associates, F-Prime Capital Partners, General Catalyst, Global Ventures, Latitud, Maverick Capital, Picus Capital, Questa Capital, Curtis Chambers | |
| Oct 1, 2020 | $12.0M Series A | 7wire Ventures, General Catalyst, Latitud, Picus Capital | |
| Sep 1, 2019 | $4.0M Series A | 7wire Ventures, General Catalyst, Latitud, Picus Capital | |
| Feb 1, 2018 | $1.0M Seed | 7wire Ventures, Latitud, Picus Capital |
